The preferred crystalline, solution, and in vacuo arrangements of 1-[[1-[2-(trifluoromethyl)-4-pyrimidinyl]-4-piperidinyl]methyl]-2-pyrrolidinone (BMY-21502) were investigated by means of single-crystal X-ray diffraction, H-1 and C-13 NMR spectroscopy, and semiempirical molecular orbital and molecular mechanics calculations. The X-ray powder diffraction pattern is also reported.
X-ray, NMR, and theoretical studies of the nootropic agent BMY-21502, a pyrrolidinone derivative
BANDOLI, GIULIANO;DOLMELLA, ALESSANDRO;NICOLINI, MARINO;
1994
Abstract
The preferred crystalline, solution, and in vacuo arrangements of 1-[[1-[2-(trifluoromethyl)-4-pyrimidinyl]-4-piperidinyl]methyl]-2-pyrrolidinone (BMY-21502) were investigated by means of single-crystal X-ray diffraction, H-1 and C-13 NMR spectroscopy, and semiempirical molecular orbital and molecular mechanics calculations. The X-ray powder diffraction pattern is also reported.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
